Indeed, the knockdown of hepatic Slc13a5 improved hepatic insulin sensitivity, prevented hepatic neutral lipid and triglyceride accumulation, and protected diet-induced NAFLD. This evidence concerns the gene SLC13A5 and metabolic dysfunction-associated steatotic liver disease.